Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Leukemia 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lymphoma 11Lymphoma, Non-Hodgkin 9Lymphoma, Large B-Cell, Diffuse 9Burkitt Lymphoma 9Myelodysplastic Syndromes 8Lymphoma, Follicular 8Leukemia, Lymphocytic, Chronic, B-Cell 8Multiple Myeloma 7Leukemia, Myeloid, Chronic-Phase 7Leukemia, Myeloid, Acute 7Lymphoma, Mantle-Cell 6Lymphoma, B-Cell, Marginal Zone 6Hodgkin Disease 6Blast Crisis 6Recurrence 5Neoplasms, Plasma Cell 5Leukemia, Myeloid, Accelerated Phase 5Graft vs Host Disease 5Dendritic Cell Sarcoma, Interdigitating 5Congenital Abnormalities 5Myeloproliferative Disorders 4Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Myelomonocytic, Juvenile 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, B-Cell 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Hematologic Neoplasms 3

Interventions

Trastuzumab 243Paclitaxel 193Cyclophosphamide 158Docetaxel 134Letrozole 113Capecitabine 113Fulvestrant 106Doxorubicin 103Bevacizumab 87Carboplatin 81exemestane 80Anastrozole 79Lapatinib 70Tamoxifen 69Albumin-Bound Paclitaxel 57palbociclib 54pertuzumab 53Taxes 51Gemcitabine 50Radiotherapy 46eribulin 43pembrolizumab 41Everolimus 41Ado-Trastuzumab Emtansine 41Vinorelbine 38130-nm albumin-bound paclitaxel 35ixabepilone 32Epirubicin 28pegfilgrastim 25liposomal doxorubicin 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Breast Neoplasms × Methylprednisolone × Clear all
NCT01105650 2017-12-28

MT2009-30

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
13 enrolled 11 charts
BreastGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡